ISIS-2

Randomized Trial of Intravenous Streptokinase, Oral Aspirin, Both, or Neither among 17187 Cases of Suspected Acute Myocardial Infarction - The Lancet - 1988

Brief Summary:

Among patients with acute MI, aspirin and streptokinase reduced 5-week vascular mortality by 20% and 23%, respectively, when compared to placebo. The combination of aspirin and streptokinase reduced the same outcome by 40%.

Reference:
http://www.ncbi.nlm.nih.gov/pubmed/2899772